World News: 13:00 GMT Wednesday 15th May 2019. [Krystal Biotech, Inc. via Globe Newswire via SPi World News]
PITTSBURGH, May 15, 2019 (GLOBE NEWSWIRE) -- , (“Krystal”) (NASDAQ: KRYS), a gene therapy company developing medicines to treat dermatological diseases, today announced that Krish S. Krishnan, chairman and chief executive officer, will be presenting at the upcoming RBC Capital Markets 2019 Healthcare Conference being held in New York.
Details for the conference and presentation are as follows:
The webcast of this presentation will be available for 90 days and can be found on the Krystal Biotech website at: .
Source: Krystal Biotech, Inc.
Globe Newswire: 13:00 GMT Wednesday 15th May 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.